WMSA
PTCT icon

Weiss Multi-Strategy Advisers’s PTC Therapeutics PTCT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-137,198
Closed -$2.33M – 1096
2013
Q4 		$2.33M Sell
137,198
-4,867
-3% -$85.5K 0.05% 317
2013
Q3 		$3.05M Buy
+142,065
New +$2.47M 0.07% 292

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Weiss Multi-Strategy Advisers's PTCT Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of PTC Therapeutics (PTCT) in Q1 2014, closing a stake of 137,198 shares — an estimated $2.33M sold.

Weiss Multi-Strategy Advisers first reported a position in PTCT in Q3 2013 and held it in 2 quarters. The position peaked at $3.05M in Q3 2013. 65 funds tracked by Wall St. Rank hold PTCT as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining PTC Therapeutics position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 137,198 PTC Therapeutics shares in Q1 2014, an estimated $2.33M.
  • Weiss Multi-Strategy Advisers first reported a position in PTC Therapeutics in Q3 2013 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's PTC Therapeutics position peaked at $3.05M in Q3 2013.
  • 65 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.